Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Acquisition

13 Jun 2005 07:00

Torex Retail PLC13 June 2005 13 June 2005 TOREX RETAIL PLC CONTINUED EXPANSION OF EUROPEAN BUSINESS WITH €4.25 MILLION ACQUISITION OF LEADING GERMAN RETAIL WORKFORCE MANAGEMENT SYSTEMS SUPPLIER Torex Retail Plc ("Torex Retail" or "the Group"), the leading internationalsystems supplier, is pleased to announce that it has acquired HoffmannDatentechnik GmbH ("Hoffmann" or "the Company") for a total consideration of€4.25 million. This consideration will be satisfied by the payment of €2.50million in cash and €1.75 million by the issue of 1,146,465 new Torex Retailordinary shares payable on completion. Hoffmann is the leading supplier of workforce management and labour schedulingsystems to the German retail market. The Company has a base of over 2,500installed systems in some 300 customers in Germany, Switzerland, Austria,Belgium, Poland, Romania and the Czech Republic. The strong customer basecomprises some of Germany's largest retailers including Praktiker (Metro),Globus (Rewe), IKEA, Toys'R'Us, Douglas and EDKA. Hoffmann is based in near Bremen and in the year ended 31 December 2004 theCompany achieved revenues of €2.5 million. Chris Moore, Chief Executive of Torex Retail commented: "Hoffmann is a longstanding and well respected supplier to the European retailmarket. For a small business it has a fantastic blue chip customer base whichbears testimony to the strength of its product set and reputation for customerservice. We are already the market leader in the UK in labour scheduling with customerslike Tesco taking our solution and Hoffmann greatly increases our capabilityacross Europe. The acquisition will give rise to significant cross sellingopportunities in the German market and also provides a product which can be soldthroughout our business, including to the large US market." Application will be made for the 1,146,465 new shares to be issued pursuant tothe consideration for the acquisition to be admitted to trading on AIM.Admission is expected to become effective on 16 June 2005. Ends. Enquiries: Torex Retail plc 0870 050 9900Chris Moore, Chief ExecutiveRichard Thompson, Finance Director Citigate Dewe Rogerson 020 7638 9571Ginny Pulbrook / Seb Hoyle About Torex Retail plc Torex Retail is a leading independent provider of cutting edge retail technologysolutions to many of the world's principal retailers. Since the company'sflotation in spring 2004 Torex Retail has achieved rapid growth across all ofits markets and has rigorously pursued its goal of becoming the provider ofchoice. As a result, the company now has a presence in all of the major marketsaround the world and has built a strong platform for future growth in line withits strategy. Torex's Retail's product and solution set spans high street andout-of-town retail as well as the petroleum and convenience sector and with over2,000 blue-chip customer relationships, including Tesco, Woolworth, Selfridges,Shell and Argos, the company has earned a leading reputation amongst retailers.Torex Retail has more than 1,000 staff based across the UK, Europe, South-EastAsia and the United States. www.torexretail.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jun 20217:00 amRNSCompletion of phase 1 of new US facility expansion
23rd Jun 20216:08 pmRNSDirector/PDMR Shareholding
10th Jun 20214:17 pmRNSHolding(s) in Company
3rd Jun 20211:37 pmRNSResult of AGM
11th May 20217:00 amRNSDirector/PDMR Shareholding
10th May 202110:00 amRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSGrant of share options
29th Apr 20214:11 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSFinal Results and Notice of AGM
20th Apr 20211:07 pmRNSHolding(s) in Company
20th Apr 202112:10 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSNotice of Results
13th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:40 pmRNSSecond Price Monitoring Extn
1st Apr 20214:36 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSInitial phase of US facility expansion complete
26th Feb 20217:00 amRNSDirectorate Change
19th Feb 20213:52 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSMove to Electronic Reporting
8th Feb 20217:00 amRNSTrading Update
5th Feb 20214:40 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSAppointment of Chief Financial Officer
6th Jan 20213:58 pmRNSPDMR Dealings
5th Jan 20217:00 amRNSConfirmation of Board appointments
4th Jan 202111:26 amRNSHoldings in Company
24th Dec 202012:56 pmRNSIssue of Equity & Total Voting Rights Replacement
24th Dec 202011:15 amRNSHoldings in Company
23rd Dec 20209:51 amRNSIssue of Equity and Total Voting Rights
4th Dec 20207:00 amRNSBoard Changes
3rd Dec 20204:54 pmRNSHoldings in Company
2nd Dec 20207:00 amRNSFirst delivery of OrthoPure® XT
27th Nov 20209:09 amRNSHoldings in Company
26th Nov 20204:02 pmRNSHoldings in Company
17th Nov 20207:00 amRNSAppointment of CEO
6th Nov 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSChange of Registered Office
26th Oct 20204:50 pmRNSHoldings in Company
7th Oct 20201:50 pmEQSHardman & Co Research: Tissue Regenix (TRX): Funded through to profitability
28th Sep 202012:24 pmRNSHoldings in Company
16th Sep 20207:42 amRNSHoldings in Company
15th Sep 20204:40 pmRNSSecond Price Monitoring Extn
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20205:33 pmRNSHoldings in Company
2nd Sep 20207:00 amRNSUnaudited Interim Results
27th Aug 20207:00 amRNSNotice of Interim Results & Investor Presentation
24th Aug 20207:00 amRNSUK distribution partner for OrthoPure® XT
18th Aug 202011:27 amRNSHoldings in Company
17th Aug 20207:00 amRNSRelocation of UK office and manufacturing facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.